Evidence map›Paper›PMID 28039167›Full record

ArticleBioinformatics (Oxford, England)2017

SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns.

Hui-Yi Lin, Dung-Tsa Chen, Po-Yu Huang, Yung-Hsin Liu, Augusto Ochoa, Jovanny Zabaleta, Donald E Mercante, Zhide Fang, Thomas A Sellers, Julio M Pow-Sang and 32 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Bioinformatics (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Natural variations inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Interactions ofCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 11 countries.

Hui-Yi LinBiostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, USA.
Dung-Tsa ChenDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Po-Yu HuangComputational Intelligence Technology Center, Industrial Technology Research Institute, Hsinchu City, Taiwan.
Yung-Hsin LiuDepartment of Biometrics, INC Research, LLC, Raleigh, NC, USA.
Augusto OchoaStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, USA.
Jovanny ZabaletaStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, USA.
Donald E MercanteBiostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, USA.
Zhide FangBiostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, USA.
Thomas A SellersDepartment of Cancer Epidemiology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Julio M Pow-SangDepartment of Genitourinary Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Chia-Ho ChengDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Rosalind EelesThe Institute of Cancer Research, London, UK.
Doug EastonCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Zsofia Kote-JaraiThe Institute of Cancer Research, London, UK.
Ali Amin Al OlamaCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Sara BenllochCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Kenneth MuirUniversity of Warwick, Coventry, UK.
Graham G GilesCancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
Fredrik WiklundDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Henrik GronbergDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Christopher A HaimanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
Johanna SchleutkerDepartment of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, Turku, Finland.
Børge G NordestgaardDepartment of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Ruth C TravisCancer Epidemiology, Nuffield Department of Population Health University of Oxford, Oxford, UK.
Freddie HamdyNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Nora PashayanCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Kay-Tee KhawCambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
Janet L StanfordDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
William J BlotInternational Epidemiology Institute, Rockville, MD, USA.
Stephen N ThibodeauDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Christiane MaierInstitute of Human Genetics University Hospital Ulm, Ulm, Germany.
Adam S KibelBrigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.
Cezary CybulskiInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lisa Cannon-AlbrightDivision of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Radka KanevaMolecular Medicine Center and Department of Medical Chemistry and Biochemistry, Medical University - Sofia, Sofia, Bulgaria.
Jyotsna BatraAustralian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and Schools of Life Science and Public Health, Queensland University of Technology, Brisbane, Australia.
Manuel R TeixeiraDepartment of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Hardev PandhaThe University of Surrey, Guildford, Surrey, UK.
Yong-Jie LuCentre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK.
PRACTICAL Consortium
Jong Y ParkDepartment of Cancer Epidemiology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Louisiana State University Health Sciences Center New Orleans · USMoffitt Cancer Center · USUniversity of Cambridge · GBInstitute of Cancer Research · GBKarolinska Institutet · SEUniversity of Oxford · GBBrigham and Women's Hospital · USCopenhagen University Hospital · DKINC Research (United States) · USIndustrial Technology Research Institute · TWInstituto Português de Oncologia Francisco Gentil · PTInternational Epidemiology Institute · USMayo Clinic in Arizona · USMedical University of Sofia · BGNational Center for Tumor Diseases · DEPomeranian Medical University · PLQueen Mary University of London · GBQueensland University of Technology · AUTampere University · FIUniversity Hospital Ulm · DE

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancerR01CA128813 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI PARK, JONG Y. · 2008 to 2012
$2.0M
Gene-Gene Interactions and Their Functional Roles in Prostate Cancer AggressivenessR21CA202417 · NCI · LSU HEALTH SCIENCES CENTER · PI LIN, HUI-YI · 2016 to 2017
$284k
Cancer Research UK 13065Cancer Research UK 14136Cancer Research UK 15007Cancer Research UK 16491Cancer Research UK 17528Cancer Research UK 19170Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/N003284/1NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA128813NCI NIH HHS R21 CA202417
6 · The paper itself

Abstract

Motivation: Testing SNP-SNP interactions is considered as a key for overcoming bottlenecks of genetic association studies. However, related statistical methods for testing SNP-SNP interactions are underdeveloped. Results: We propose the SNP Interaction Pattern Identifier (SIPI), which tests 45 biologically meaningful interaction patterns for a binary outcome. SIPI takes non-hierarchical models, inheritance modes and mode coding direction into consideration. The simulation results show that SIPI has higher power than MDR (Multifactor Dimensionality Reduction), AA_Full, Geno_Full (full interaction model with additive or genotypic mode) and SNPassoc in detecting interactions. Applying SIPI to the prostate cancer PRACTICAL consortium data with approximately 21 000 patients, the four SNP pairs in EGFR-EGFR , EGFR-MMP16 and EGFR-CSF1 were found to be associated with prostate cancer aggressiveness with the exact or similar pattern in the discovery and validation sets. A similar match for external validation of SNP-SNP interaction studies is suggested. We demonstrated that SIPI not only searches for more meaningful interaction patterns but can also overcome the unstable nature of interaction patterns. Availability and Implementation: The SIPI software is freely available at http://publichealth.lsuhsc.edu/LinSoftware/ . Contact: hlin1@lsuhsc.edu. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

Epistasis, GeneticPolymorphism, Single NucleotideSoftwareStatistics as TopicErbB ReceptorsGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleMatrix Metalloproteinase 16Models, GeneticProstatic NeoplasmsEGFR protein, humanErbB ReceptorsMatrix Metalloproteinase 16MMP16 protein, human

Identifiers

PMID28039167
PMCPMC5860469
OpenAlexW2567343548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.